SO-YOUN PARK (Inha University Hospital)

Prof. Park began her career , Kyung Hee University Medical Center in 2007. In 2012, she then went on to complete her Infectious Disease fellowship at the Asan Medical Center. She is now an associate professor of the Hospital Medicine at Inha University. She also serves in a variety of professional and public roles, including as a member of the Regulatory Reform Committee of the Ministry of Health and Welfare, and currently as an ethics committee member of both the Korean Academy of Medical Sciences and the Korean Association of Internal Medicine.

As a researcher, she is particularly interested in the self-determination rights of people with disabilities and continues to conduct research in this area. In particular, she aims to create an environment in which individuals with disabilities can independently make decisions about their own treatment and care, and she is actively engaged in related research and educational activities. In addition, she continues to conduct research related to artificial intelligence (AI), particularly focusing on its ethical application and integration in healthcare and clinical decision-making.

1. Disability and health literacy in Korea: evidence from a national survey. Sci Rep (2026). https://doi.org/10.1038/s41598-026-51076-y

2. Analysis of academic stress factors in basic medical science courses among medical students: suggestions for curriculum improvement.Korean Journal of Medical Education 2026;38(1):54-63.

3. Disparities in periodontitis risk and healthcare use among individuals with disabilities in Korea: a retrospective cohort study. BMC Oral Health. 2025 Apr 1;25(1):470.

4. Association of Hospital- and Patient-Level Characteristics on SARS-CoV-2 Infection and COVID-19 Mortality among Patients in Korean Long-Term Care Hospitals: A Multilevel Analysis. Jpn J Infect Dis. 2025 Dec 26. doi: 10.7883/yoken.JJID.2025.063.

5. Comparative analysis of genetic testing utilization rates among people with and without disabilities in South Korea from 2016 to 2019, focusing on malignant neoplasms: A national population-based study. Cancer Med. 2024 May;13(9):e7102.